On Tuesday, the U.S. Food and Drug Administration approved a device to continuously monitor blood sugar and ketone levels in people with diabetes.

System offers real-time diabetic ketoacidosis warnings

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes